Relationship between plasma and red blood cell concentrations of quinine in Brazilian children with uncomplicated Plasmodium falciparummalaria on oral therapy

Neste estudo foi determinada a relação entre as concentrações plasmáticas e eritrocitárias de quinina em crianças com malária falciparum não complicada, oriundas de área endêmica da Região Amazônica. A quinina foi detrminada por cromatografia líquida de alta eficiência. No estado de equilíbrio, a relação foi 1,89 ± 1,25 variando de 1,05 a 2,34. Estes resultados demonstraram que a quinina não se concentra nos eritrócitos das crianças e caracterizaram a ausência de diferença racial nesta relação.

Division of labor between M and P visual pathways: different visual pathways minimize joint entropy differently

Visual perception and action are strongly linked with parallel processing channels connecting the retina, the lateral geniculate nucleus, and the input layers of the primary visual cortex. Achromatic vision is provided by at least two of such channels formed by the M and P neurons. These cell pathways are similarly organized in primates having different lifestyles, including species that are diurnal, nocturnal, and which exhibit a variety of color vision phenotypes. We describe the M and P cell properties by 3D Gábor functions and their 3D Fourier transform. The M and P cells occupy different loci in the Gábor information diagram or Fourier Space. This separation allows the M and P pathways to transmit visual signals with distinct 6D joint entropy for space, spatial frequency, time, and temporal frequency. By combining the M and P impacts on the cortical neurons beyond V1 input layers, the cortical pathways are able to process aspects of visual stimuli with a better precision than it would be possible using the M or P pathway alone. This performance fulfils the requirements of different behavioral tasks.

Oral live attenuated human rotavirus vaccine (RotarixTM) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children

In a large Phase III trial conducted in 10 Latin American countries, the safety and efficacy of the live attenuated monovalent rotavirus vaccine RIX4414 was evaluated in 15,183 healthy infants followed up during the first two years of life. Belém was the only site in Brazil included in this multicentre trial. The study in Belém included a subset of 653 infants who were followed up until 24 months of age for protection against severe rotavirus gastroenteritis. These subjects were randomly assigned in a 1:1 ratio to receive two doses of vaccine (n = 328) or two doses of placebo (n = 325) at approximately two and four months of age. Of the 653 enrolled infants, 23 dropped out during the study period. For the combined two-year period, the efficacy of RIX4414 was 72.3% [95% confidence interval (CI) 37.5-89.1%] against severe rotavirus-related gastroenteritis, reaching a protection rate of 81.8% (95% CI 36.4-96.6%) against circulating wild-type G9 rotavirus strains. It is concluded that two doses of RIX4414 are highly efficacious against severe rotavirus gastroenteritis in Belém during the first two years of life and provide high protection against the worldwide emergence and spread of G9P[8] strains.